文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性(AMD)与全因及特定病因死亡风险的关联:NHANES 2005-2008

Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

基于美国NHANES 2005-2008的5603名40岁及以上参与者的前瞻性队列研究,通过眼底照片评估AMD状态。中位随访4.5年后,仅晚期AMD与全因死亡风险倍增(HR 2.01,95%CI 1.00-4.03)及非心血管和非癌症死亡风险增高3倍以上(HR 3.42,95%CI 1.38-8.49)独立相关,早期AMD或任何AMD与死亡风险无独立关联。

要点

  • 晚期AMD与全因死亡风险独立相关(HR 2.01,95%CI 1.00-4.03)
  • 晚期AMD与非心血管非癌症死亡风险独立相关(HR 3.42,95%CI 1.38-8.49)
  • 早期AMD或任何AMD与全因及特定病因死亡风险无独立关联

核心结论

  • 仅晚期AMD独立关联全因死亡及非心血管非癌症死亡风险,提示晚期AMD可能是生物学衰老的标志,或由未测量混杂因素导致。

研究设计与样本

  • 基于人群的前瞻性队列研究,纳入NHANES 2005-2008阶段5603名40岁及以上参与者,通过数字眼底图像判定AMD状态,采用加权数据分析。

主要发现

  • 中位随访4.5年(四分位距3.6-5.6年),433例(5.3%)全因死亡,其中361例(83.1%)无AMD,54例(11.5%)早期AMD,18例(5.4%)晚期AMD,72例(16.9%)任何AMD。
  • 未调整时,早期、晚期或任何AMD的全因及特定病因死亡率均高于无AMD者。
  • 调整混杂因素后,仅晚期AMD与全因死亡风险倍增相关(HR 2.01;95%CI 1.00-4.03)及非心血管非癌症死亡风险增高3倍以上相关(HR 3.42;95%CI 1.38-8.49)。
  • AMD存在或早期AMD与全因或特定病因死亡无关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Age-related macular degeneration (AMD) is the leading cause of irreversible visual impairment and blindness in the United States if subretinal neovascularization is left untreated. Knowledge of the association between AMD and survival is informative for underlying mechanisms of AMD. OBJECTIVE: To examine the association between AMD and risk of all-cause and specific-cause mortality in a representative US sample. DESIGN, SETTING, AND PARTICIPANTS: This population-based prospective cohort study included 5603 participants 40 years or older who responded to the National Health and Nutrition Examination Survey (NHANES) in the 2005-2008 phase. Retinal photographs were graded as early, late, or no AMD. All analyses accounted for the complex and stratified design of NHANES with weighted data. Risks of all-cause mortality were assessed with Cox proportional hazards regression models; risks of specific-cause mortality, with Fine and Gray competing risks regression models. Time to death was counted from baseline to date of death or December 31, 2011, whichever came first. Data analysis was conducted from April 1 through 30, 2018. EXPOSURES: Age-related macular degeneration status as determined by digital fundus images. MAIN OUTCOMES AND MEASURES: Mortality resulting from all causes and specific causes until December 31, 2011. RESULTS: Among the 5603 participants (52.6% female [n = 2793] and 77.1% white [n = 3017]; mean [SE] age, 56.4 [0.4] years), weighted prevalence of any AMD was 6.6%, with 386 (5.8%) having early AMD and 55 (0.8%) having late AMD. After a median follow-up of 4.5 years (interquartile range, 3.6-5.6 years), 433 (5.3%) died of all causes, of whom 361 (83.1%) had no AMD, 54 (11.5%) had signs of early AMD, 18 (5.4%) had signs of late AMD, and 72 (16.9%) had any AMD at baseline. Overall, unadjusted all-cause and specific-cause mortality rates were higher for those participants who had early, late, or any AMD compared with no AMD. However, after adjusting confounding factors, only late AMD was associated with more than a doubling of all-cause mortality (hazard ratio [HR], 2.01; 95% CI, 1.00-4.03) and more than a 3-fold higher risk of mortality due to causes other than cardiovascular disease and cancer (HR, 3.42; 95% CI, 1.38-8.49). No association was identified between AMD presence or early AMD and all-cause or specific-cause mortality. CONCLUSIONS AND RELEVANCE: In this study's findings, only late AMD was independently associated with all-cause mortality and mortality due to causes other than cardiovascular disease and cancer, indicating that late AMD may be a marker of biological aging. Alternatively, this association may be due to unmeasured or inadequately assessed confounding factors for late AMD.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhu Z, Wang W, Keel S, et al. Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008. JAMA Ophthalmol. 2019. PMID: 30570662. doi:10.1001/jamaophthalmol.2018.6150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。